Article

Detection of anti-DS DNA as diagnostic tool

University of Amsterdam, Amsterdamo, North Holland, Netherlands
Annals of the Rheumatic Diseases (Impact Factor: 10.38). 03/1981; 40(1):45-9. DOI: 10.1136/ard.40.1.45
Source: PubMed

ABSTRACT

The diagnostic significance of anti-dsDNA determinations was evaluated in 2 different groups of patients. When the immunofluorescence technique (IFT) with Crithidia luciliae and the Farr assay with 3H-labelled-PM2 DNA were applied to a selected panel of 536 sera from patients with various well-defined autoimmune diseases, positive results were obtained only with serum samples from patients with systemic lupus erythematosus (SLE). On the other hand when we screened 4431 sera sent to our laboratory for diagnostic reasons, we observed a high incidence of antibodies to dsDNA in patients who did not fulfil the preliminary American Rheumatism Association's criteria for SLE and did not have the diagnosis SLE. Furthermore, a significant number of the positive sera showed peculiar behaviour in that they were positive only in the IFT on Crithidia luciliae and not in the Farr assay.

Full-text preview

Available from: bmj.com
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently, a new radioimmunoassay—the polyethylene glycol (PEG) assay—was introduced to measure antibodies to double-stranded (ds) DNA. In this method, polyethylene glycol precipitation of formed 3H-DNA/antiDNA complexes is used instead of the ammonium sulfate precipitation used in the Farr assay. In contrast to the Farr assay, with which only high-avidity antibodies to dsDNA are detected, the PEG assay also reportedly measures anti–dsDNA of relatively low avidity. We studied whether this gain in antibody measurement results in loss of specificity for systemic lupus erythematosus. When the PEG assay was applied to a selected panel of 440 sera from patients with various well-defined autoimmune diseases and to a group of 197 normal human control sera, matched for sex and age to the patients, the method was found to be fairly specific for systemic lupus erythematosus, although the sera from some patients with myasthenia gravis and some with autoimmune liver disease were also found positive. Screening of 352 additional serum specimens, sent to our laboratory for diagnostic reasons, revealed that, with the PEG assay, an extra population of relatively low-avidity antibodies to dsDNA—missed by the Farr assay—was detected. Upon clinical evaluation, we found that the patients in whom such antibodies were detected generally fulfilled a number of the preliminary criteria of the American Rheumatism Association for systemic lupus erythematosus, but that this diagnosis often was not made. We claim that the presence of low-avidity antiDNA characterizes a milder form of the disease in which patients often show only a single clinical feature of the disease. We conclude that results of the PEG assay add valuable diagnostic and clinical information to results obtained by the Farr assay.
    No preview · Article · Jun 1982 · Arthritis & Rheumatology
  • [Show abstract] [Hide abstract]
    ABSTRACT: In a series of 1,734 patients, anti-nuclear antibodies (ANA) were found in 311 patients (18 p. 100) in 1/10 dilution and 91 patients (5 p. 100) in 1/100 dilution. Analysis of these 91 patients revealed 65 collagenoses including 22 disseminated lupus erythomatosis (DLE) and 27 rheumatoid disease (RD). Serological analysis of ANA below 1/100 dilution revealed anti DNA antibodies with Farr's test and on crithidia, and soluble anti-nuclear antigen antibodies, mainly in patients with DLE. ANA were detected in 22 out of 24 patients (92 p. 100) with DLE with over 1/100 dilution, in 27 of 115 patients with RD (23 p. 100), but only in 2 of 100 normal subjects (2 p. 100).
    No preview · Article · Jun 1982
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently, a new radioimmunoassay--the polyethylene glycol (PEG) assay--was introduced to measure antibodies to double-stranded (ds) DNA. In this method, polyethylene glycol precipitation of formed 3H-DNA/antiDNA complexes is used instead of the ammonium sulfate precipitation used in the Farr assay. In contrast to the Farr assay, with which only high-avidity antibodies to dsDNA are detected, the PEG assay also reportedly measures anti-dsDNA of relatively low avidity. We studied whether this gain in antibody measurement results in loss of specificity for systemic lupus erythematosus. When the PEG assay was applied to a selected panel of 440 sera from patients with various well-defined autoimmune diseases and to a group of 197 normal human control sera, matched sex and age to the patients, the method was found to be fairly specific for systemic lupus erythematosus, although the sera from some patients with myasthenia gravis and some with autoimmune liver disease were also found positive. Screening of 352 additional serum specimens, sent to our laboratory for diagnostic reasons, revealed that, with the PEG assay, an extra population of relatively low-avidity antibodies to dsDNA--missed by the Farr assay--was detected. Upon clinical evaluation, we found that the patients in whom such antibodies were detected generally fulfilled a number of the preliminary criteria of the American Rheumatism Association for systemic lupus erythematosus, but that this diagnosis often was not made. We claim that the presence of low-avidity antiDNA characterizes a milder form of the disease in which patients often show only a single clinical feature of the disease. We conclude that results of the PEG assay add valuable diagnostic and clinical information to results obtained by the Farr assay.
    No preview · Article · Jul 1982 · Arthritis & Rheumatology
Show more